Alliqua BioMedical (ADYX) Stock Price, News & Analysis

Company Overview

Alliqua BioMedical, Inc. was a medical-device company focused on developing, manufacturing and commercializing advanced wound-care products. Its offerings were designed to support the management of chronic and acute wounds, including products based on tissue-repair technologies, wound dressings and biologic materials.

The company’s historical portfolio included Biovance, a dehydrated human amniotic membrane allograft used in wound management, as well as the MIST Therapy system, a low-frequency ultrasound technology acquired through its purchase of Celleration. Alliqua marketed its products primarily in the United States through direct sales and distribution channels.

Alliqua BioMedical later entered into a transaction with Adynxx, a clinical-stage biotechnology company, and ceased operating as an independent wound-care business. The combined company adopted the Adynxx name and used the OTCMKTS:ADYX symbol. Current leadership and operations associated with the former Alliqua BioMedical business are not separately available.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 10/14/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:ADYX
• CIK: 1054274
• Web: www.alliqua.com
• Phone: (415) 512-7740
• Fax: 215-702-8535
• Employees: 6
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 1.65